|
Volumn 307, Issue 3, 2012, Pages 252-253
|
Mandatory HPV vaccination
|
Author keywords
[No Author keywords available]
|
Indexed keywords
WART VIRUS VACCINE;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG USE;
EDUCATION PROGRAM;
HEALTH CARE ACCESS;
HEALTH CARE DELIVERY;
HEALTH CARE DISTRIBUTION;
HEALTH CARE POLICY;
HEALTH SURVEY;
HUMAN;
INFECTION PREVENTION;
LETTER;
MANDATORY PROGRAM;
PAPILLOMAVIRUS INFECTION;
PREVENTIVE HEALTH SERVICE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
TREATMENT PLANNING;
UNITED STATES;
VACCINATION;
FEMALE;
LEGAL ASPECT;
MALE;
NOTE;
POLICY;
POLITICS;
FEMALE;
HUMANS;
MALE;
MANDATORY PROGRAMS;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
POLITICS;
PUBLIC POLICY;
VACCINATION;
|
EID: 84856016547
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.2018 Document Type: Letter |
Times cited : (5)
|
References (5)
|